AS

Aaron Sasson

Director at BioSight

Mr. Sasson is a member of the Board of Directors of CancerLinQ™ LLC, a subsidiary of the American Society of Clinical Oncology (ASCO) established for the development and operations of the CancerLinQ™ initiative, as well as The Conquer Cancer Foundation (CCF) of the American Society of Clinical Oncology (ASCO), which seeks dramatic advances in the prevention, diagnosis, treatment, and cure of all types of cancer.

Mr. Sasson is also the founder of several technology comapnies, lead by Mr. Sasson to technological and commercial success.